What the research found

A Cedars-Sinai study compared small intestinal samples from 49 people with treated hypothyroidism to 323 controls, finding roughly double the prevalence of SIBO in the hypothyroid group. The hypothyroid patients showed different patterns of bacterial overgrowth—particularly higher Klebsiella—compared to controls who more commonly had E. coli or Lactobacillus when SIBO was detected. A separate analysis using medical records from a large health database similarly reported a doubled risk of SIBO diagnosis in hypothyroid patients, with some suggestion that levothyroxine treatment may reduce this risk.

These findings align with the established biological plausibility of a thyroid-gut axis. Hypothyroidism slows intestinal motility and reduces stomach acid, both of which could theoretically favour bacterial overgrowth in the small bowel.

Why it matters for you

If you're tracking thyroid function as part of your health protocol, this suggests one more reason to keep TSH and free T4/T3 optimized: gut bacterial balance may be affected when thyroid status drifts. Hypothyroid symptoms—bloating, constipation, sluggish digestion—overlap heavily with SIBO, so it's worth asking whether poor thyroid control is driving your GI symptoms rather than SIBO itself. If you're being evaluated for SIBO (typically via breath test or culture), make sure your thyroid has been adequately assessed and treated first; normalizing thyroid function might resolve your symptoms without additional intervention.

For those using thyroid support protocols, this reinforces the value of monitoring both TSH and symptom resolution rather than stopping at symptom reduction alone.

Caveats

• Culture-based definition: The SIBO diagnosis relied on bacterial cultures, which are known to underestimate total bacteria and preferentially detect certain gram-negative species. DNA sequencing would capture a fuller picture but wasn't the primary diagnostic criterion here.
• Small hypothyroid subgroup: Only 49 hypothyroid patients in the main analysis, limiting statistical precision.
• Control population not healthy: The "controls" were endoscopy patients with clinical symptoms, not healthy volunteers, potentially inflating the apparent difference.
• Observational database analysis: The health records study defines SIBO by chart documentation (usually breath-test-based diagnosis), which itself is not validated and may simply reflect diagnostic labeling patterns rather than true bacterial load.
• Retrospective and chart-dependent: Limited ability to verify diagnoses or capture confounding factors.